Cerebain Biotech (CBBT) Short Interest Ratio & Short Volume

$0.0009

0.00 (0.00%)

(As of 09/2/2021)

Stock Analysis

Cerebain Biotech Short Interest Data

Short Selling Cerebain Biotech ?

Sign up to receive the latest short interest report for Cerebain Biotech and its competitors with MarketBeat's FREE newsletter.

Report Date	Total Shares Sold Short	Dollar Volume Sold Short	Change from Previous Report	Percentage of Float Shorted	Price on Report Date
7/30/2021	17,500 shares	$33.25	No Change	N/A	$0.00
6/30/2021	100 shares	$0.40	-99.7%	N/A	$0.00
6/15/2021	30,000 shares	$204.00	-41.5%	N/A	$0.01
5/28/2021	51,300 shares	$769.50	+212.8%	N/A	$0.02
5/14/2021	16,400 shares	$738.00	-56.6%	N/A	$0.05
4/30/2021	37,800 shares	$2,060.10	-16.0%	N/A	$0.05
4/15/2021	45,000 shares	$1,710.00	+78.6%	N/A	$0.04
3/31/2021	25,200 shares	$1,474.20	+127.0%	N/A	$0.06
3/15/2021	11,100 shares	$865.80	-59.9%	N/A	$0.08
2/26/2021	27,700 shares	$4,612.05	-37.9%	N/A	$0.17
2/12/2021	44,600 shares	$17,394.00	+47.2%	N/A	$0.39
1/29/2021	30,300 shares	$3,969.30	-85.5%	N/A	$0.13
1/15/2021	34,500 shares	$4,243.50	-64.4%	N/A	$0.12
12/31/2020	42,200 shares	$3,057.39	+22.3%	N/A	$0.07
12/15/2020	34,500 shares	$755.55	-64.4%	N/A	$0.02
11/30/2020	97,000 shares	$0.00	No Change	N/A	$0.00

What is Cerebain Biotech's current short interest?: Short interest is the volume of Cerebain Biotech shares that have been sold short but have not yet been covered or closed out. As of July 30th, investors have sold 17,500 shares of CBBT short. Learn More on Cerebain Biotech's current short interest.
Is Cerebain Biotech's short interest increasing or decreasing?: Cerebain Biotech saw a increase in short interest in the month of July. As of July 30th, there was short interest totaling 17,500 shares, an increase of ∞ from the previous total of 0 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.
Which stocks are the most shorted right now?: As of the most recent reporting period, the following stocks had the largest short interest positions: Advanced Micro Devices, Inc. ($9.46 billion), Block, Inc. ($7.91 billion), S&P Global Inc. ($7.79 billion), Analog Devices, Inc. ($7.10 billion), Moderna, Inc. ($6.65 billion), Aon plc ($5.10 billion), Charter Communications, Inc. ($5.09 billion), Wayfair Inc. ($3.82 billion), Teladoc Health, Inc. ($2.64 billion), and Nuance Communications, Inc. ($2.45 billion). View all of the most shorted stocks.

What does it mean to sell short Cerebain Biotech stock?: Short selling CBBT is an investing strategy that aims to generate trading profit from Cerebain Biotech as its price is falling. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.
How does a short squeeze work against Cerebain Biotech?: A short squeeze for Cerebain Biotech occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of CBBT, which in turn drives the price of the stock up even further.
How often is Cerebain Biotech's short interest reported?: Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including CBBT, twice per month. The most recent reporting period available is July, 30 2021.

Related Companies:

Short Interest Tools:

This page (OTCMKTS:CBBT) was last updated on 5/10/2024 by MarketBeat.com Staff

From Our Partners